Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis
- PMID: 9021256
Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis
Abstract
The pathogenesis of sporadic amyotrophic lateral sclerosis (ALS) is unknown, but several observations suggest that glutamate could participate in selective motor neuron degeneration. Extracellular levels of glutamate are elevated in ALS. Synaptic concentrations of glutamate are regulated by high-affinity glutamate transport, and defects in glutamate transport have also been observed in ALS tissue. Three sodium-dependent glutamate transporters have now been identified: a neuronal transporter EAAC1, and two astroglial transporters GLT-1 and GLAST. The defect in glutamate transport in ALS appears to be relatively specific for the GLT-1 subtype. The role of chronic excess glutamate and glutamate transporter loss has been investigated in experimental paradigms, where it was found that excitotoxicity could account for selective motor neuron degeneration. These culture paradigms have demonstrated that motor neurons are sensitive to glutamate toxicity via non-NMDA receptors and that various agents (e.g., antioxidants, glutamate release inhibitors, non-NMDA receptor antagonists) can be neuroprotective. These experimental studies will provide a basis for understanding the primary and secondary role of glutamate in motor neuron death and will provide important insight into possible therapeutic interventions.
Similar articles
-
Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS).J Cell Sci. 2004 Oct 15;117(Pt 22):5417-26. doi: 10.1242/jcs.01411. Epub 2004 Oct 5. J Cell Sci. 2004. PMID: 15466883
-
Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis.Adv Neurol. 1995;68:7-20; discussion 21-7. Adv Neurol. 1995. PMID: 8787245 Review.
-
Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis.Muscle Nerve. 2002 Oct;26(4):438-58. doi: 10.1002/mus.10186. Muscle Nerve. 2002. PMID: 12362409 Review.
-
Serotonergic mechanisms in amyotrophic lateral sclerosis.Int J Neurosci. 2006 Jul;116(7):775-826. doi: 10.1080/00207450600754087. Int J Neurosci. 2006. PMID: 16861147 Review.
-
Chronic elevation of extracellular glutamate due to transport blockade is innocuous for spinal motoneurons in vivo.Neurochem Int. 2009 Mar-Apr;54(3-4):186-91. doi: 10.1016/j.neuint.2008.09.015. Epub 2008 Dec 3. Neurochem Int. 2009. PMID: 19100799
Cited by
-
A model of human neural networks reveals NPTX2 pathology in ALS and FTLD.Nature. 2024 Feb;626(8001):1073-1083. doi: 10.1038/s41586-024-07042-7. Epub 2024 Feb 14. Nature. 2024. PMID: 38355792 Free PMC article.
-
Neuromuscular Development and Disease: Learning From in vitro and in vivo Models.Front Cell Dev Biol. 2021 Oct 27;9:764732. doi: 10.3389/fcell.2021.764732. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34778273 Free PMC article. Review.
-
Delayed Onset Muscle Soreness (DOMS): The Repeated Bout Effect and Chemotherapy-Induced Axonopathy May Help Explain the Dying-Back Mechanism in Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases.Brain Sci. 2021 Jan 15;11(1):108. doi: 10.3390/brainsci11010108. Brain Sci. 2021. PMID: 33467407 Free PMC article.
-
A multistationary loop model of ALS unveils critical molecular interactions involving mitochondria and glucose metabolism.PLoS One. 2020 Dec 17;15(12):e0244234. doi: 10.1371/journal.pone.0244234. eCollection 2020. PLoS One. 2020. PMID: 33332476 Free PMC article.
-
Astrocyte DISC1 contributes to cognitive function in a brain region-dependent manner.Hum Mol Genet. 2020 Oct 10;29(17):2936-2950. doi: 10.1093/hmg/ddaa180. Hum Mol Genet. 2020. PMID: 32803234 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous